On December 25, 2025, JD Health, in collaboration with German premium nutrition brand VIKPRO and INDENA, the world's leading quercetin raw material supplier, officially released the “White Paper on Lung Cleansing and Protection Nutrition and Health” (hereinafter referred to as the “White Paper”). As an authoritative industry report focused on lung-cleansing and lung-protecting nutrition, the White Paper comprehensively analyzes China's current lung health landscape, industry development trends, and evolving consumer demands. Leveraging collaborative efforts across industry, academia, and research, it provides crucial guidance for standardized industry development, corporate innovation and upgrading, and scientifically informed consumer care.
Currently, China faces an increasingly severe lung health crisis. According to white paper data, the number of chronic respiratory disease patients in China has exceeded 420 million. The prevalence of chronic obstructive pulmonary disease (COPD) among those aged 20 and above reaches 8.6%, rising to 13.7% among those aged 40 and above. Annual medical expenditures for five major lung diseases—including lung cancer and pneumonia—approach 270 billion yuan. Simultaneously, factors like smog pollution, occupational dust exposure, smoking, and secondhand smoke continue to impact public lung health. Over 80 million occupationally high-risk individuals and 360 million smokers form a substantial demand base for lung-cleansing products. Concurrently, as consumer health awareness significantly increases, “lung care” has shifted from traditional treatment to proactive prevention. In 2024, e-commerce sales of related nutritional supplements grew by 210% year-on-year, with the market size projected to exceed 100 billion yuan by 2028.
The release of this white paper brings together the core strengths of three key partners. JD Health leverages platform big data to gain insights into consumer demand and market dynamics, VIKPRO provides user testimonials highlighting the potent effects of its proprietary quercetin brand, while INDENA contributes raw material R&D support through patented technology. The white paper clearly defines the core attributes of the lung-cleansing category, positioning it as a special dietary supplement distinct from pharmaceuticals and health foods. It achieves key benefits—such as moisturizing lung care and respiratory function regulation—through scientifically formulated natural active ingredients. Among these, quercetin—as the key active ingredient—undergoes PHYTOSOME® phospholipid delivery technology processing, achieving 20 times higher bioavailability than standard quercetin. This innovation has become an industry benchmark. Leveraging this phospholipid delivery advantage, VIKPRO has secured the title of China's top-selling quercetin brand for two consecutive years, as certified by Euromonitor International.
Regarding product and consumption trends, the white paper indicates that lung-cleansing products are evolving toward precision efficacy, natural ingredients, and convenient formats. Domestic products primarily utilize ingredients derived from traditional Chinese medicine, focusing on nourishing yin, reducing noise, relieving coughs, and dissolving phlegm. Cross-border products, meanwhile, emphasize immune support and predominantly adopt capsule or tablet formulations. Consumer demand exhibits all-age and specialized characteristics, extending from middle-aged and elderly patients and smokers to younger working professionals and children. Customized products addressing scenarios like smog protection, throat and lung care, and chronic disease management are highly favored. 35.2% of consumers prioritize product functionality as their primary consideration, while 26.5% focus on ingredients, signaling that rational consumption has become the mainstream trend.
A representative from JD Health's specialized healthcare division stated that moving forward, the company will use the white paper as a guide to deepen collaborations with partners such as VIKPRO and INDENA in areas including core ingredient research, formulation innovation, and channel integration. By implementing an omnichannel strategy combining online and offline channels, alongside professional science communication and scenario-based marketing, high-quality lung-cleansing products will reach a broader consumer base. Concurrently, the three parties will jointly promote lung health awareness to support the development of a lung health prevention and treatment system under the “Healthy China” initiative.
The joint release of this white paper by the three parties not only fills a gap in industry research on lung-cleansing products but also establishes a comprehensive ecosystem collaboration model spanning the entire chain from raw materials to products to consumption. Driven by policy support, rising consumer demand, and technological innovation, the lung-cleansing health industry is entering a golden period of high-quality development, safeguarding the respiratory health of the nation.
